文献速递生殖医学产科

滋养细胞IL-27与Gal-9协同驱动早孕期蜕膜Tim-3+ Treg细胞聚集

Newly characterized decidual Tim-3+ Treg cells are abundant during early pregnancy and driven by IL-27 coordinately with Gal-9 from trophoblasts.
PubMed 文献 · Hum Reprod · 2020-01-01

该研究探讨早孕期蜕膜Tim-3+ Treg细胞聚集机制及其与复发性流产(RPL)的关系。动物实验纳入80只正常妊娠小鼠,人体研究纳入32例正常早孕和23例RPL患者的蜕膜组织等。发现IL-27和Gal-9协同诱导Tim-3+ Treg细胞,RPL患者中IL-27和Gal-9异常表达与免疫耐受受损相关。

要点

  • 小鼠子宫Tim-3+ Treg细胞在妊娠第6.5天达峰值,占Treg细胞40-70%。
  • 正常早孕蜕膜约60% Treg细胞为Tim-3阳性,其中近90%表达PD-1。
  • RPL患者孕6-9周蜕膜CD4+ T细胞和Treg细胞Tim-3表达显著降低。

核心结论

  • 滋养细胞分泌的IL-27和Gal-9协同激活CD4+ T细胞和Treg细胞Tim-3信号通路,促进Tim-3+ Treg细胞聚集。
  • RPL患者中IL-27和Gal-9异常表达与免疫耐受受损相关。

研究设计与样本

  • 动物研究纳入80只正常妊娠小鼠,采用流式细胞术检测Tim-3+ CD4+ T细胞和Tim-3+ Treg细胞比例。
  • 人体研究收集32例正常早孕和23例RPL患者蜕膜组织进行流式分析,15例正常早孕胎盘组织进行免疫组化。
  • 收集5例正常早孕、5例RPL和5例一次流产史妇女胎盘组织进行western blot,30例正常早孕妇女血样用于体外实验。
  • 研究时间2017年1月至2019年3月。

主要发现

  • 小鼠子宫Tim-3+ Treg细胞比例随妊娠波动,妊娠第6.5天(E6.5)达峰值,E18.5降至非妊娠水平,脾脏中无变化。
  • 妊娠小鼠子宫中Tim-3+ Treg细胞占Treg细胞40-70%,脾脏中丰度低得多。
  • E6.5时约60%蜕膜Treg细胞为Tim-3阳性,其中近90%为PD-1阳性;而Tim-3阴性Treg细胞仅约16%表达PD-1。
  • 阻断Tim-3信号通路降低Treg细胞比例并导致胚胎吸收。
  • RPL患者孕6-9周蜕膜CD4+ T细胞和Treg细胞Tim-3表达显著低于匹配孕周的正常妊娠妇女。

临床怎么用

  • Tim-3+ Treg细胞及其诱导因子IL-27和Gal-9可能作为RPL免疫耐受评估的潜在标志物。
  • 针对IL-27/Gal-9-Tim-3通路的干预可能为RPL提供治疗思路。

局限性

  • 因早孕中晚期蜕膜组织获取受限,未研究人蜕膜Tim-3+ CD4+ T细胞和Tim-3+ Treg细胞在整个妊娠期的动力学变化。
  • 因蜕膜中Tim-3+ Treg细胞数量少,缺乏其功能性抑制数据。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

STUDY QUESTION: What is the mechanism of Tim-3+ regulatory T (Treg)-cell accumulation in the decidua during early pregnancy and is its disruption associated with recurrent pregnancy loss (RPL)? SUMMARY ANSWER: IL-27 and Gal-9 secreted by trophoblasts activate the Tim-3 signaling pathway in CD4+ T cells and Treg cells and so promote accumulation of Tim-3+ Treg cells, the abnormal expression of IL-27 and Gal-9 is associated with impaired immunologic tolerance in RPL patients. WHAT IS KNOWN ALREADY: Tim-3+ Treg cells are better suppressors of Teff cell proliferation, and display higher proliferative activity than Tim-3- Treg cells. Tim-3+ Treg cells are tissue-specific promoters of T-cell dysfunction in many tumors. These cells express a unique factor that influences and shapes the tumor microenvironment. STUDY DESIGN, SIZE, DURATION: The animal study included 80 normal pregnant mice. In human study, decidua tissues in the first trimester for flow cytometry analysis were collected from 32 normal pregnant women and 23 RPL patients. Placenta tissues for immunohistochemistry analysis were collected from 15 normal pregnant women. Placenta tissues for western blot analysis were collected from 5 normal pregnant women, 5 RPL patients and 5 women who have experienced one miscarriage. Blood samples for in vitro experiments were collected from 30 normal pregnant women. This study was performed between January 2017 and March 2019. PARTICIPANTS/MATERIALS, SETTING, METHODS: In this study, we investigated the kinetics of Tim-3+ CD4+ T-cell accumulation, and the proportions of Tim-3+ Treg cells throughout murine pregnancies using flow cytometry. We compared Tim-3 expression on decidual CD4+ T cells and Treg cells during normal pregnancies with expression on the same cell populations in women suffering from RPL. IL-27 and Gal-9 transcription and protein expression in the placenta were determined by RT-PCR and western blot, respectively. An in vitro co-culture model consisting of peripheral CD4+ T cells and primary trophoblasts from early pregnancy was used to mimic the maternal-fetal environment. MAIN RESULTS AND THE ROLE OF CHANCE: The percentage of Tim-3+ Treg cells present in mouse uteri fluctuates as gestation proceeds but does not change in the spleen. Levels of Tim3+ Treg cells in uteri peaked at pregnancy Day 6.5 (E 6.5), then progressively diminished, and fell to non-pregnant levels by E18.5. In pregnant mice, Tim-3+ Treg cells constituted 40-70% of Treg cells in uteri but were present at much lower abundance in spleens. About 60% of decidual Treg cells were Tim-3 positive at E6.5. Of these decidual Tim3+ Treg cells, nearly 90% were PD-1 positive. However, only about 16% of Tim3- Treg cells expressed PD-1. Blocking the Tim-3 signaling pathway decreased the proportion of Treg cells and led to embryo resorption. Moreover, much lower Tim-3 expression was observed on CD4+ T cells and Treg cells in women who had suffered from RPL at 6-9 gestational weeks compared with those who had normal pregnancies at matched gestations. In a normal pregnancy, Tim-3 expression on decidual CD4+ T cells is induced initially by IL-27. Then Gal-9-Tim-3 interaction promotes differentiation of decidual Tim-3+ CD4+ T cells into Treg cells. IL-27 and Gal-9 cooperatively induced Tim-3+ Treg cells in vitro. LARGE SCALE DATA: N/A. LIMITATIONS, REASONS FOR CAUTION: We did not investigate the kinetics of human decidual Tim-3+ CD4+ T and Tim-3+ Treg cell populations throughout pregnancy due to limited availability of second and third trimester decidua. In addition, functional suppressive data on the decidual Tim-3+ Treg cells are lacking due to limited and low quantities of these cells in decidua. WIDER IMPLICATIONS OF THE FINDINGS: These findings might have therapeutic clinical implications in RPL. STUDY FUNDING/COMPETING INTEREST(S): This study was supported by research grants from the National Natural Science Foundation of China (No. 81871186) and National Key Research & Developmental Program of China (2018YFC1003900, 2018YFC1003904). The authors declare no conflict of interest.

来源:Hum Reprod,查看原文。版权归原作者所有。

引用

  1. Hu X, Zhu Q, Wang Y, et al. Newly characterized decidual Tim-3+ Treg cells are abundant during early pregnancy and driven by IL-27 coordinately with Gal-9 from trophoblasts. Hum Reprod. 2020. PMID: 33107565. doi:10.1093/humrep/deaa223

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。